Manufacturers Life Insurance Company, The Vor Biopharma Inc. Transaction History

Manufacturers Life Insurance Company, The

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$2.1 - $3.35 $14,861 - $23,707	-7,077 Reduced 40.91%	10,221 $21,000
Q2 2023 Aug 11, 2023	BUY	$3.09 - $5.33 $53,450 - $92,198	17,298 New	17,298 $53,000
Q1 2022 May 20, 2022	SELL	$6.04 - $12.23 $61,299 - $124,122	-10,149 Closed	0 $0
Q4 2021 Feb 16, 2022	BUY	$11.32 - $18.02 $114,886 - $182,884	10,149 New	10,149 $118,000
Q2 2021 Aug 12, 2021	SELL	$18.65 - $38.78 $119,863 - $249,239	-6,427 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$30.96 - $54.08 $198,979 - $347,572	6,427 New	6,427 $277,000

41.2M

9.3K

100

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $33.1M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.